Skelaxin, Metaxalone News

King Pharma Questions Remain Posted Fri May 15, 11:15 am ET Posted By: Jason Napodano, CFA Last year was challenging for King Pharmaceuticals , with most of the company's key products facing increasing competition, generic threats, and declining prescription trends.

Continue reading "Pfizer among companies polluting US water supplies"

Federal scientists testing for pharmaceuticals in water have been finding significantly more medicine residues in sewage downstream from public treatment facilities that handle waste from drugmakers.

Add King Pharmaceuticals to the list of drug companies shedding staff. The specialty drug manufacturer announced on Tuesday that it was eliminating 760 jobs - totaling 22 percent of its workforce.

King Pharmaceuticals, Inc et al v. EON Labs, Inc ., E.D.N.Y , Jan. 20, 2009 In a highly publicized case, King Pharmaceuticals brought an action against Eon Labs on patents relating to methods of informing ...

A New York court has overturned the patent on King Pharmaceuticals Inc.'s muscle relaxant Skelaxin, the company said Wednesday.

King Pharmaceuticals, Inc. reported today that the U.S. District Court for the Eastern District of New York in the case of King Pharmaceuticals, Inc., et al.